{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:40:44Z","timestamp":1792734044996,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01950-2","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:26:59Z","timestamp":1792733219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of histone deacetylase 3 alleviates lithocholic acid-induced intrahepatic cholestasis by enhancing expression of bile acid and lipid homeostasis-related genes"],"prefix":"10.1038","author":[{"given":"Jing-shu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-cheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-chang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"1950_CR1","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.mayocp.2020.01.015","volume":"95","author":"MB Hilscher","year":"2020","unstructured":"Hilscher MB, Kamath PS, Eaton JE. Cholestatic liver diseases: a primer for generalists and subspecialists. Mayo Clin Proc. 2020;95:2263\u201379.","journal-title":"Mayo Clin Proc"},{"key":"1950_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0168-8278(90)90265-S","volume":"11","author":"RE Poupon","year":"1990","unstructured":"Poupon RE, Eschwege E, Poupon R. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC study group. J Hepatol. 1990;11:16\u201321.","journal-title":"J Hepatol"},{"key":"1950_CR3","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","volume":"148","author":"GM Hirschfield","year":"2015","unstructured":"Hirschfield GM, Mason A, Luketic V, Lindor K, Gordon SC, Mayo M, et al. Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology. 2015;148:751\u201361.e8.","journal-title":"Gastroenterology"},{"key":"1950_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33070-1","volume":"8","author":"RF van Golen","year":"2018","unstructured":"van Golen RF, Olthof PB, Lionarons DA, Reiniers MJ, Alles LK, Uz Z, et al. FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis. Sci Rep. 2018;8:16529.","journal-title":"Sci Rep"},{"key":"1950_CR5","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(24)01303-5","volume":"404","author":"A Tanaka","year":"2024","unstructured":"Tanaka A, Ma X, Takahashi A, Vierling JM. Primary biliary cholangitis. Lancet. 2024;404:1053\u201366.","journal-title":"Lancet"},{"key":"1950_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","volume":"20","author":"T Narita","year":"2019","unstructured":"Narita T, Weinert BT, Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol. 2019;20:156\u201374.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1950_CR7","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1007\/s11010-025-05274-3","volume":"480","author":"R Tang","year":"2025","unstructured":"Tang R, Zha H, Liu R, Lv J, Cao D, Li L. Sodium butyrate attenuates liver fibrogenesis via promoting H4K8 crotonylation. Mol Cell Biochem. 2025;480:4467\u201381.","journal-title":"Mol Cell Biochem"},{"key":"1950_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114312","volume":"183","author":"CH Lee","year":"2021","unstructured":"Lee CH, Choi Y, Cho H, Bang IH, Hao L, Lee SO, et al. Histone deacetylase 8 inhibition alleviates cholestatic liver injury and fibrosis. Biochem Pharmacol. 2021;183:114312.","journal-title":"Biochem Pharmacol"},{"key":"1950_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1053\/j.gastro.2020.10.008","volume":"160","author":"SO Aseem","year":"2021","unstructured":"Aseem SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, De Assuncao TM, Hamdan FH, et al. Epigenomic evaluation of cholangiocyte transforming growth factor-beta signaling identifies a selective role for histone 3 lysine 9 acetylation in biliary fibrosis. Gastroenterology. 2021;160:889\u2013905.e10.","journal-title":"Gastroenterology"},{"key":"1950_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1096\/fj.201700612r","volume":"32","author":"M Li","year":"2018","unstructured":"Li M, Hong W, Hao C, Li L, Wu D, Shen A, et al. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice. FASEB J. 2018;32:500\u201311.","journal-title":"FASEB J"},{"key":"1950_CR11","doi-asserted-by":"crossref","unstructured":"Hao L, Bang IH, Wang J, Mao Y, Yang JD, Na SY, et al. ERRgamma suppression by Sirt6 alleviates cholestatic liver injury and fibrosis. JCI Insight. 2020;5:e137566.","DOI":"10.1172\/jci.insight.137566"},{"key":"1950_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00408-025-00798-3","volume":"203","author":"L Hong","year":"2025","unstructured":"Hong L, Ni M, Xue F, Jiang T, Wu X, Li C, et al. The role of HDAC3 in pulmonary diseases. Lung. 2025;203:47.","journal-title":"Lung"},{"key":"1950_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03295-y","volume":"12","author":"Z Qiu","year":"2021","unstructured":"Qiu Z, Ming H, Lei S, Zhou B, Zhao B, Yu Y, et al. Roles of HDAC3-orchestrated circadian clock gene oscillations in diabetic rats following myocardial ischaemia\/reperfusion injury. Cell Death Dis. 2021;12:43.","journal-title":"Cell Death Dis"},{"key":"1950_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.kint.2017.02.023","volume":"92","author":"W Lin","year":"2017","unstructured":"Lin W, Zhang Q, Liu L, Yin S, Liu Z, Cao W. Klotho restoration via acetylation of peroxisome proliferation-activated receptor gamma reduces the progression of chronic kidney disease. Kidney Int. 2017;92:669\u201379.","journal-title":"Kidney Int"},{"key":"1950_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00109-021-02141-8","volume":"100","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cao W. Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases. J Mol Med. 2022;100:43\u201351.","journal-title":"J Mol Med"},{"key":"1950_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09524-z","volume":"10","author":"N Liang","year":"2019","unstructured":"Liang N, Damdimopoulos A, Goni S, Huang Z, Vedin LL, Jakobsson T, et al. Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARalpha. Nat Commun. 2019;10:1684.","journal-title":"Nat Commun"},{"key":"1950_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcmgh.2022.10.015","volume":"15","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhou P, Xing W, Chen L, Zhou Y, Yang H, et al. GLIS2 prevents hepatic fibrosis by competitively binding HDAC3 to inhibit hepatic stellate cell activation. Cell Mol Gastroenterol Hepatol. 2023;15:355\u201372.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1950_CR18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3109\/13880209.2014.900810","volume":"52","author":"JC Han","year":"2014","unstructured":"Han JC, Yu J, Gao YJ. Lipidomics investigation of reversal effect of glycyrrhizin (GL) towards lithocholic acid (LCA)-induced alteration of phospholipid profiles. Pharm Biol. 2014;52:1624\u20138.","journal-title":"Pharm Biol"},{"key":"1950_CR19","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1073\/pnas.1213364110","volume":"110","author":"M Malvaez","year":"2013","unstructured":"Malvaez M, McQuown SC, Rogge GA, Astarabadi M, Jacques V, Carreiro S, et al. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc Natl Acad Sci USA. 2013;110:2647\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1950_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.gendis.2022.02.003","volume":"10","author":"E Gijbels","year":"2023","unstructured":"Gijbels E, De Muynck K, Vanderborght B, Meese T, Van Nieuwerburgh F, Vanlander A, et al. Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease. Genes Dis. 2023;10:18\u201321.","journal-title":"Genes Dis"},{"key":"1950_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ebiom.2016.11.021","volume":"14","author":"C Hardie","year":"2016","unstructured":"Hardie C, Green K, Jopson L, Millar B, Innes B, Pagan S, et al. Early molecular stratification of high-risk primary biliary cholangitis. EBioMedicine. 2016;14:65\u201373.","journal-title":"EBioMedicine"},{"key":"1950_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1101\/sqb.2011.76.011494","volume":"76","author":"Z Sun","year":"2011","unstructured":"Sun Z, Feng D, Everett LJ, Bugge A, Lazar MA. Circadian epigenomic remodeling and hepatic lipogenesis: lessons from HDAC3. Cold Spring Harb Symp Quant Biol. 2011;76:49\u201355.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1950_CR23","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1002\/ptr.8326","volume":"38","author":"T Wang","year":"2024","unstructured":"Wang T, Tian T, Zhu Z, Fang S, Zhang L, Peng X, et al. Gardenia jasminoides Ellis. Polysaccharides alleviated cholestatic liver injury by increasing the production of butyric acid and FXR activation. Phytother Res. 2024;38:5363\u201375.","journal-title":"Phytother Res"},{"key":"1950_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1422770","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang J, Chen L, Zhao SS, Du C, Fan YZ, Liu HX, et al. FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate. Front Pharmacol. 2024;15:1422770.","journal-title":"Front Pharmacol"},{"key":"1950_CR25","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1053\/j.gastro.2024.05.014","volume":"167","author":"R Wang","year":"2024","unstructured":"Wang R, Li B, Huang B, Li Y, Liu Q, Lyu Z, et al. Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis. Gastroenterology. 2024;167:733\u201349.e3.","journal-title":"Gastroenterology"},{"key":"1950_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12250-018-0057-7","volume":"33","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Wang Q, Yang Q, Tang J, Xu C, Gai D, et al. Histone deacetylase 3 inhibitor suppresses hepatitis C virus replication by regulating apo-A1 and LEAP-1 expression. Virol Sin. 2018;33:418\u201328.","journal-title":"Virol Sin"},{"key":"1950_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00500-z","volume":"8","author":"SR Pasricha","year":"2017","unstructured":"Pasricha SR, Lim PJ, Duarte TL, Casu C, Oosterhuis D, Mleczko-Sanecka K, et al. Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. Nat Commun. 2017;8:403.","journal-title":"Nat Commun"},{"key":"1950_CR28","doi-asserted-by":"publisher","first-page":"E150","DOI":"10.1152\/ajpendo.00465.2017","volume":"315","author":"J Zhang","year":"2018","unstructured":"Zhang J, Xu Z, Gu J, Jiang S, Liu Q, Zheng Y, et al. HDAC3 inhibition in diabetic mice may activate Nrf2, preventing diabetes-induced liver damage and FGF21 synthesis and secretion, leading to aortic protection. Am J Physiol Endocrinol Metab. 2018;315:E150\u2013E62.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1950_CR29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/hep.510270232","volume":"27","author":"S Ceryak","year":"1998","unstructured":"Ceryak S, Bouscarel B, Malavolti M, Fromm H. Extrahepatic deposition and cytotoxicity of lithocholic acid: studies in two hamster models of hepatic failure and in cultured human fibroblasts. Hepatology. 1998;27:546\u201356.","journal-title":"Hepatology"},{"key":"1950_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.907271","volume":"13","author":"W Li","year":"2022","unstructured":"Li W, Chen H, Qian Y, Wang S, Luo Z, Shan J, et al. Integrated lipidomics and metabolomics study of four chemically induced mouse models of acute intrahepatic cholestasis. Front Pharmacol. 2022;13:907271.","journal-title":"Front Pharmacol"},{"key":"1950_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/hep.510290115","volume":"29","author":"T Kawaguchi","year":"1999","unstructured":"Kawaguchi T, Sakisaka S, Sata M, Mori M, Tanikawa K. Different lobular distributions of altered hepatocyte tight junctions in rat models of intrahepatic and extrahepatic cholestasis. Hepatology. 1999;29:205\u201316.","journal-title":"Hepatology"},{"key":"1950_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-4939-9420-5_15","volume":"1981","author":"S Van Campenhout","year":"2019","unstructured":"Van Campenhout S, Van Vlierberghe H, Devisscher L. Common bile duct ligation as model for secondary biliary cirrhosis. Methods Mol Biol. 2019;1981:237\u201347.","journal-title":"Methods Mol Biol"},{"key":"1950_CR33","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1074\/jbc.M311015200","volume":"279","author":"Y Inoue","year":"2004","unstructured":"Inoue Y, Yu AM, Inoue J, Gonzalez FJ. Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation. J Biol Chem. 2004;279:2480\u20139.","journal-title":"J Biol Chem"},{"key":"1950_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.ejcb.2008.08.002","volume":"87","author":"I Weinhofer","year":"2008","unstructured":"Weinhofer I, Kunze M, Rampler H, Forss-Petter S, Samarut J, Plateroti M, et al. Distinct modulatory roles for thyroid hormone receptors TRalpha and TRbeta in SREBP1-activated ABCD2 expression. Eur J Cell Biol. 2008;87:933\u201345.","journal-title":"Eur J Cell Biol"},{"key":"1950_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0378-1119(01)00586-8","volume":"273","author":"CK Zhang","year":"2001","unstructured":"Zhang CK, Lin W, Cai YN, Xu PL, Dong H, Li M, et al. Characterization of the genomic structure and tissue-specific promoter of the human nuclear receptor NR5A2 (hB1F) gene. Gene. 2001;273:239\u201349.","journal-title":"Gene"},{"key":"1950_CR36","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1093\/nar\/gkq227","volume":"38","author":"D Chanda","year":"2010","unstructured":"Chanda D, Xie YB, Choi HS. Transcriptional corepressor SHP recruits SIRT1 histone deacetylase to inhibit LRH-1 transactivation. Nucleic Acids Res. 2010;38:4607\u201319.","journal-title":"Nucleic Acids Res"},{"key":"1950_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1074\/jbc.M605023200","volume":"282","author":"JY Cha","year":"2007","unstructured":"Cha JY, Repa JJ. The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. J Biol Chem. 2007;282:743\u201351.","journal-title":"J Biol Chem"},{"key":"1950_CR38","doi-asserted-by":"publisher","first-page":"E222","DOI":"10.1152\/ajpendo.00189.2001","volume":"282","author":"H Sone","year":"2002","unstructured":"Sone H, Shimano H, Sakakura Y, Inoue N, Amemiya-Kudo M, Yahagi N, et al. Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. Am J Physiol Endocrinol Metab. 2002;282:E222\u201330.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1950_CR39","doi-asserted-by":"publisher","first-page":"28410","DOI":"10.1074\/jbc.M300553200","volume":"278","author":"SY Oh","year":"2003","unstructured":"Oh SY, Park SK, Kim JW, Ahn YH, Park SW, Kim KS. Acetyl-CoA carboxylase beta gene is regulated by sterol regulatory element-binding protein-1 in liver. J Biol Chem. 2003;278:28410\u20137.","journal-title":"J Biol Chem"},{"key":"1950_CR40","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/s42255-024-01029-4","volume":"6","author":"AK Hauck","year":"2024","unstructured":"Hauck AK, Mehmood R, Carpenter BJ, Frankfurter MT, Tackenberg MC, Inoue SI, et al. Nuclear receptor corepressors non-canonically drive glucocorticoid receptor-dependent activation of hepatic gluconeogenesis. Nat Metab. 2024;6:825\u201336.","journal-title":"Nat Metab"},{"key":"1950_CR41","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1128\/MCB.23.15.5122-5131.2003","volume":"23","author":"T Ishizuka","year":"2003","unstructured":"Ishizuka T, Lazar MA. The N-CoR\/histone deacetylase 3 complex is required for repression by thyroid hormone receptor. Mol Cell Biol. 2003;23:5122\u201331.","journal-title":"Mol Cell Biol"},{"key":"1950_CR42","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.1198125","volume":"331","author":"D Feng","year":"2011","unstructured":"Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, et al. A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science. 2011;331:1315\u20139.","journal-title":"Science"},{"key":"1950_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00182-7","volume":"8","author":"A Ferrari","year":"2017","unstructured":"Ferrari A, Longo R, Fiorino E, Silva R, Mitro N, Cermenati G, et al. HDAC3 is a molecular brake of the metabolic switch supporting white adipose tissue browning. Nat Commun. 2017;8:93.","journal-title":"Nat Commun"},{"key":"1950_CR44","first-page":"1455","volume":"14","author":"P Polly","year":"2000","unstructured":"Polly P, Herdick M, Moehren U, Baniahmad A, Heinzel T, Carlberg C. VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor partnership. FASEB J. 2000;14:1455\u201363.","journal-title":"FASEB J"},{"key":"1950_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00772-5","volume":"8","author":"SM Armor","year":"2017","unstructured":"Armor SM, Remsberg JR, Damle M, Sidoli S, Ho WY, Li Z, et al. An HDAC3-PROX1 corepressor module acts on HNF4alpha to control hepatic triglycerides. Nat Commun. 2017;8:549.","journal-title":"Nat Commun"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01950-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01950-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01950-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:27:00Z","timestamp":1792733220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01950-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":45,"alternative-id":["1950"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01950-2","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"15 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}